These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 848647)

  • 1. Coagulation factor XIIa (activated Hageman factor) inhibitor from adult Schistosoma mansoni.
    Tsang VC; Hubbard WJ; Damian RT
    Am J Trop Med Hyg; 1977 Mar; 26(2):243-7. PubMed ID: 848647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration and mode of action of an inhibitor for activated Hageman factor (factor XIIa) of the intrinsic blood coagulation pathway from Schistosoma mansoni.
    Tsang VC; Damian RT
    Blood; 1977 Apr; 49(4):619-33. PubMed ID: 843620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae.
    Foster CB; Flanigan TP; Kazura JW; Dumenco LL; Ratnoff OD
    J Lab Clin Med; 1991 May; 117(5):344-52. PubMed ID: 1902251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
    Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
    Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Hageman factor activation.
    Nossel HL; Rubin H; Drillings M; Hsieh R
    J Clin Invest; 1968 May; 47(5):1172-80. PubMed ID: 5645860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XI and factor XII as targets for new anticoagulants.
    Weitz JI
    Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor).
    Hedner U; Martinsson G
    Thromb Res; 1978 Jun; 12(6):1015-23. PubMed ID: 99837
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of factors XII (Hageman) and XI (PTA) by skin contact.
    Nossel HL
    Proc Soc Exp Biol Med; 1966 May; 122(1):16-7. PubMed ID: 5944866
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.
    Park HS; Gu J; You HJ; Kim JE; Kim HK
    Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the contact pathway in thrombus propagation.
    Gruber A
    Thromb Res; 2014 May; 133 Suppl 1():S45-7. PubMed ID: 24759142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system.
    Hitomi Y; Ikari N; Fujii S
    Haemostasis; 1985; 15(3):164-8. PubMed ID: 3161808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
    Koenig JM; Chahine A; Ratnoff OD
    J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.